POSACONAZOLE 100 MG OFEK PHARMA

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

POSACONAZOLE

متاح من:

OFEK PHARMA LTD, ISRAEL

ATC رمز:

J02AC04

الشكل الصيدلاني:

TABLETS DELAYED RELEASE

تركيب:

POSACONAZOLE 100 MG

طريقة التعاطي:

PER OS

نوع الوصفة الطبية :

Required

المصنعة من قبل:

HAIMEN PHARMA INC., CHINA

المجال العلاجي:

POSACONAZOLE

الخصائص العلاجية:

Treatment of the following fungal infections in adults:- Invasive aspergillosis in patients with disease that is refractory to amphotericin B or itraconazole or in patients who are intolerant of these medicinal products;- Fusariosis in patients with disease that is refractory to amphotericin B or in patients who are intolerant of amphotericin B.- Chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patient intolerant to itraconazole.- Coccidioidomycosis in patients with disease refractory to amphotericin B, itraconazole or fludonazole or in patient intolerant to these medicinal products.- Zygomycosis in patients intolerant of or with disease that is refractory to alternative therapy.Refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective antifungal therapy.These are also indicated for prophylaxis of invasive fungal infections in the following patients:- Patients receiving remission-induction chemotherapy for acute myelogenous leukemia (AML) or myelodysplatic syndrome (MDS) expected to result in prolonged neutropenia who are at high-risk of developing invasive fungal infections.-Hematopoietic stem cell transplant (HSCT) recipients who are undergoing high-dose immunosuppressive therapy for graft versus host disease and who are at high-risk of developing invasive fungal infections.

تاريخ الترخيص:

2022-10-18

نشرة المعلومات

Patient leaflet in accordance with the Pharmacists’ Regulations
(Preparations) - 1986
This medicine is dispensed with a doctor’s prescription only
Posaconazole 100 mg Ofek Pharma
Delayed release tablets
Active ingredient
Each tablet contains posaconazole 100 mg
Inactive ingredients and allergens: See section 2 under ‘Important
information about some of this
medicine’s ingredients’ and section 6 ‘Additional
information’.
Read the entire leaflet carefully before you start using this
medicine. This leaflet contains concise
information about Posaconazole 100 mg Ofek Pharma. If you have any
further questions, consult
your doctor or pharmacist.
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if it
seems to you that their medical condition is similar to yours.
Posaconazole 100 mg Ofek Pharma is intended for use in adults aged 18
years and older.
1. What is this medicine intended for?
Posaconazole 100 mg Ofek Pharma is used to prevent and treat different
types of fungal infections
Posaconazole 100 mg Ofek Pharma is used to treat the following types
of fungal infections in adults
when other antifungal medicines have not worked or their intake has
had to be stopped:

infections caused by fungi of the Aspergillus family and resistant to
treatment with amphotericin B
or itraconazole, or when the patient cannot receive these medicines;

infections caused by fungi of the Fusarium family and resistant to
treatment with amphotericin B,
or when the patient cannot receive this medicine;

infections caused by fungi that cause conditions known as
chromoblastomycosis and mycetoma
and resistant to treatment with itraconazole, or when the patient
cannot receive this medicine;

infections caused by a fungus called Coccidioides and resistant to
treatment with amphotericin B,
itraconazole or fluconazole, or when the patient cannot receive these
medicines.

fungal infection called Zygomycosis in patients intolerant to or with
disease that is refractory to
alternati